IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rhenman & Partners Asset Management AB

Q1 2017 Holdings

Filed 2017-04-19 | 104 holdings | $50.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$6.7M130,00013.1%
AbbVie Inc(ABBV)COM00287Y109$8.5M130,00016.7%
BioMarin Pharmaceutical Inc(BMRN)COM09061G101$11.0M125,00021.6%
Biogen Inc(BIIB)COM09062X103$18.6M68,00036.7%
PreviousPage 3 of 3